Oral and topical analgesia in pediatric electrodiagnostic studies

Area of Science:

• Pediatric Neurophysiology
• Pain Management
• Clinical Trials

Background:

• Electrodiagnostic examinations like nerve conduction studies (NCS) and needle electromyography (EMG) are often perceived as painful by children.
• Effective pain reduction strategies are crucial for improving patient compliance and can yield neurocognitive and neuropsychiatric benefits.

Purpose of the Study:

• To evaluate the efficacy of combined oral and topical analgesics (COTA), oral analgesics (OA), and placebo in mitigating pain during NCS/EMG in pediatric patients.
• To compare pain scores across different analgesic interventions and age groups.

Main Methods:

• A double-blind, randomized, placebo-controlled trial was conducted involving pediatric patients undergoing NCS/EMG.
• Participants were stratified into two age groups (6 months–6 years and 7–18 years) and assigned to COTA, OA, or placebo arms.
• Pain was assessed using the Modified Behavioral Pain Scale (MBPS) and Faces Pain Scale-Revised (FPS-R).

Main Results:

• No significant differences in guardian-reported pain scores (FPS-R) were observed across all intervention arms for NCS and EMG when combining age groups.
• A significant difference in pain severity distribution was found between OA and placebo groups for NCS in children aged 7–18 years (p=0.007).
• EMG procedures were consistently more painful than NCS (p<0.05). In children aged 6 months–6 years, COTA significantly reduced pain scores when at least 10 muscles were sampled during EMG (p=0.014).

Conclusions:

• Pediatric pain perception during NCS/EMG is complex, indicating a need for enhanced pain management strategies.
• Procedural factors, such as the number of muscles sampled during EMG, can influence analgesic effectiveness.
• Further research is warranted to optimize pain management protocols for pediatric electrodiagnostic procedures.